Daily Care for Eczema the Key for Successful Management

    New Disease Management Program Arms Patients

    THORNHILL, ON, Jan. 22 /CNW/ - New help has arrived for Canadians living
with eczema, just in time for the season that causes patients particular
difficulty; winter. Galderma Canada Inc. today announced the launch of a
Disease Management Program, Eczema Daily Care, a resource which will help
patients understand their disease and instruct them on the ideal ways to
manage it.
    The key is education and early detection.
    "It is imperative that patients educate themselves on eczema and
understanding what causes their disease to flare, and take proactive measures
so they can avoid or detect inflammation," states Dr. Mani Raman,
Dermatologist, Vaughan, Ontario. "Recognizing the first signs of an eczema
flare is very important because treating a little itch or a few bumps is a lot
easier and takes a lot less time than treating a big flare."
    Through a series of interactive tools, Eczema Daily Care will provide
patients with information on a wide variety of eczema care topics, including;
tips on how to manage a flare, continual therapy for optimal disease
management and expert testimonial along with personal stories of dealing with
eczema. The program also consists of an interactive website -
www.eczemadailycare.ca - where patients can go for more information.
    It all begins, however, with the appreciation that eczema is a chronic
disease with the potential to have a serious impact on quality of life, and
must be treated as such. "It is important to understand that there is not a
single therapy for treating eczema. Eczema must be treated with a continuum of
care approach, including skin emollients, topical corticosteroids and topical
calcineurin inhibitors," advises Dr. Raman. The continuum of care model
highlighted in the Disease Management Program begins with a moisturizer with
emollient properties. When a patient is doing well and their eczema is not
active or inflamed, they should be using an emollient daily to keep their skin
moisturized. Depending on the severity and patient history, topical
corticosteroids or topical calcineurin inhibitors may be used to bring the
disease back under control, at which point, a patient should return to using a
moisturizer with emollient properties.
    Amanda Creswell-Melville, the President of The Eczema Society of Canada,
a mother of two children with eczema, as well as a patient herself,
understands the impact the disease can have on a person's life. "Even the
smallest flare can escalate quickly. Eczema is tremendously itchy, causing
patients to scratch uncontrollably, which may cause the red patches to bleed,
become infected and possibly leave scars. Overall, quality of life is greatly
impacted by the disease." The impact of eczema is especially felt in children,
adds Creswell-Melville. "If the flared area is visually apparent, as with
eczema on the hands and face, children can begin to feel self-conscious and
isolated from other kids. As a result, eczema often affects not only the
patient, but their whole family."
    Eczema, however, is not a life-sentence, according to Dr. Raman. "As
clinicians, we have a responsibility to equip our patients with as much
information as possible in order to give them a legitimate chance to overcome
their disease and maintain a high quality of life. The Eczema Daily Care
program is exactly the kind of tool that will help physicians educate their

    About Eczema

    Eczema, also known as atopic dermatitis (AD), is a chronic skin disease
characterized by a red, itchy rash on the skin's surface. Patients with eczema
have skin that is very sensitive to many substances, such as soap, wool and
detergents. Once skin is exposed to a trigger, it releases chemicals to the
surface of the skin causing the patient to itch. Itching in turn initiates a
further chemical release of substances leading to inflammation and additional
itching, instigating a degenerative cycle.
    Eczema is a common condition, with a Canadian prevalence of approximately
10 per cent to 15 per cent in children under the age five, of which
40 per cent still have the disease as adults.(1)

    For more information about the Disease Management Program, eczema and
available treatment options, patients can speak to their dermatologist, or
visit www.eczemadailycare.ca. For more information on The Eczema Society of
Canada, visit www.eczemahelp.ca.

    (1) Ellis C, Luger T, Abeck D, Allen R, Graham-Brown RA, de Prost Y,
        et al. International Consensus Conference on Atopic Dermatitis II
        (ICCAD II): clinical update and current treatment strategies. Br.J
        Dermatol. 2003;148 Suppl 63:3-10.

For further information:

For further information: about this press release, or to arrange an
interview with a physician/patient spokesperson, please contact: Chrome
Communications, (905) 567-1406: Alon Barmapov, ext. 223, (647) 405-1352,
alon@chromecommunications.ca, or Tiana DiMichele, ext. 225, (416) 666-5331,

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890